Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Eur J Clin Microbiol Infect Dis ; 41(2): 235-243, 2022 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-34734347

RESUMEN

Microbiological confirmation is rare in children with active tuberculosis; therefore, a more accurate test is needed to detect pulmonary tuberculosis in children. In this multicenter study, we evaluated the utility of the Xpert MTB/RIF Ultra (Ultra) on sputum, an assay recommended by the World Health Organization to test for childhood tuberculosis in high-burden settings. Children with symptoms suggestive of tuberculosis were enrolled at three hospitals in China and categorized as having active tuberculosis or nontuberculosis. The sensitivity and specificity of Ultra were 42.1% (48/114) and 99.0% (208/210), respectively. Using three MTB culture results as the reference, the sensitivity of Ultra in the subset of 38 children with culture-positive and 76 children with culture-negative was 68.4% (26/38) and 28.9% (22/76), respectively(p < 0.001). A single MTB culture combined with a single Ultra could detect 54 (54/114,47.4%) cases with active TB, while repeated MTB culture combined with a single Ultra detected 60 (60/114, 52.6%) cases with active TB(p = 0.427). Among 155 children (58 with TB and 97 with RTIs) simultaneously tested with the Ultra and Xpert MTB/RIF (Xpert), the sensitivity of the Xpert (24.1%, 14/58) was lower than that of the Ultra (41.4%, 24/58; p = 0.048). Eight children were found to have rifampin-resistant MTB strains. The Xpert MTB/RIF Ultra assay should be implemented to test for pulmonary tuberculosis in children to achieve higher confirmation rates.


Asunto(s)
Antibióticos Antituberculosos/farmacología , Rifampin/farmacología , Esputo/microbiología , Tuberculosis Pulmonar/diagnóstico , Adolescente , Niño , Preescolar , China , Pruebas Diagnósticas de Rutina , Farmacorresistencia Bacteriana/efectos de los fármacos , Humanos , Lactante , Recién Nacido , Mycobacterium tuberculosis/efectos de los fármacos , Estudios Retrospectivos , Sensibilidad y Especificidad , Tuberculosis/diagnóstico
2.
BMC Cancer ; 21(1): 553, 2021 May 17.
Artículo en Inglés | MEDLINE | ID: mdl-33993869

RESUMEN

BACKGROUND: The tumor microenvironment acts a pivotal part in the occurrence and development of tumor. However, there are few studies on the microenvironment of papillary renal cell carcinoma (PRCC). Our study aims to explore prognostic genes related to tumor microenvironment in PRCC. METHODS: PRCC expression profiles and clinical data were extracted from The Cancer Gene Atlas (TCGA) and Gene Expression Omnibus (GEO) database. Immune/stromal scores were performed utilizing the ESTIMATE algorithm. Three hundred fifty-seven samples were split into two groups on the basis of median immune/stromal score, and comparison of gene expression was conducted. Intersect genes were obtained by Venn diagrams. Hub genes were selected through protein-protein interaction (PPI) network construction, and relevant functional analysis was conducted by DAVID. We used Kaplan-Meier analysis to identify the correlations between genes and overall survival (OS) and progression-free survival (PFS). Univariate and multivariate cox regression analysis were employed to construct survival model. Cibersort was used to predict the immune cell composition of high and low risk group. Combined nomograms were built to predict PRCC prognosis. Immune properties of PRCC were validated by The Cancer Immunome Atlas (TCIA). RESULTS: We found immune/stromal score was correlated with T pathological stages and PRCC subtypes. Nine hundred eighty-nine differentially expressed genes (DEGs) and 1169 DEGs were identified respectively on the basis of immune and stromal score. Venn diagrams indicated that 763 co-upregulated genes and 4 co-downregulated genes were identified. Kaplan-Meier analysis revealed that 120 genes were involved in tumor prognosis. Then PPI network analysis identified 22 hub genes, and four of which were significantly related to OS in patients with PRCC confirmed by cox regression analysis. Finally, we constructed a prognostic nomogram which combined with influence factors. CONCLUSIONS: Four tumor microenvironment-related genes (CD79A, CXCL13, IL6 and CCL19) were identified as biomarkers for PRCC prognosis.


Asunto(s)
Biomarcadores de Tumor/genética , Carcinoma de Células Renales/mortalidad , Neoplasias Renales/mortalidad , Nomogramas , Microambiente Tumoral/genética , Factores de Edad , Anciano , Antígenos CD79/genética , Carcinoma de Células Renales/diagnóstico , Carcinoma de Células Renales/genética , Carcinoma de Células Renales/inmunología , Quimiocina CCL19/genética , Quimiocina CXCL13/genética , Conjuntos de Datos como Asunto , Estudios de Factibilidad , Femenino , Regulación Neoplásica de la Expresión Génica/inmunología , Humanos , Interleucina-6/genética , Estimación de Kaplan-Meier , Riñón/inmunología , Riñón/patología , Neoplasias Renales/diagnóstico , Neoplasias Renales/genética , Neoplasias Renales/inmunología , Masculino , Persona de Mediana Edad , Modelos Genéticos , Clasificación del Tumor , Mapas de Interacción de Proteínas/genética , Mapas de Interacción de Proteínas/inmunología , Curva ROC , Medición de Riesgo/métodos , Medición de Riesgo/estadística & datos numéricos , Factores Sexuales , Microambiente Tumoral/inmunología , Regulación hacia Arriba/inmunología
3.
Materials (Basel) ; 15(18)2022 Sep 17.
Artículo en Inglés | MEDLINE | ID: mdl-36143780

RESUMEN

To solve the global shortage of land and offshore resources, the development of deep-sea resources has become a popular topic in recent decades. Deep-sea composites are widely used materials in abyssal resources extraction, and corresponding marine exploration vehicles and monitoring devices for deep-sea engineering. This article firstly reviews the existing research results and limitations of marine composites and equipment or devices used for resource extraction. By combining the research progress of smart composites, deep-sea smart composite materials with the three characteristics of self-diagnosis, self-healing, and self-powered are proposed and relevant studies are summarized. Finally, the review summarizes research challenges for the materials, and looks forward to the development of new composites and their practical application in conjunction with the progress of composites disciplines and AI techniques.

4.
Paediatr Int Child Health ; 42(3-4): 127-132, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-37587754

RESUMEN

BACKGROUND: Congenital tuberculosis (CTB) is relatively rare and most patients are described in case reports. AIM: To investigate the clinical characteristics of CTB in 26 children. METHODS: A retrospective analysis of 26 children with CTB from January 2013 to December 2021 in Changsha Central Hospital in Central Southern China was undertaken. RESULTS: The median age at onset was 25 days (17-33) and within 4 weeks of age in approximately 73% of cases. Of 24 mothers (including two mothers of twins), 18 (75.0%) were asymptomatic during pregnancy, and four were diagnosed with tuberculosis prenatally. The numbers of tuberculous meningitis, tuberculous encephalitis and liver TB were 17 (65.4%), five (19.2%) and four (15.4%), respectively. The main symptoms were fever (n = 18, 69.2%) and cough (n = 16, 61.5%). Positive rates of T-SPOT.TB, acid-fast bacilli smear, culture of Mycobacterium tuberculosis and GeneXpert MTB/RIF test were, respectively, 84.2% (16/19), 42.3% (11/26), 43.5% (10/23) and 83.3% (5/6). Radiograph or computed tomography demonstrated typical pulmonary tuberculous lesions in all cases and the head magnetic resonance imaging (MRI) showed marked meningeal enhancement or parenchymal lesions in seven cases (26.9%). One case had drug-resistant TB. During follow-up, nine cases had varying degrees of liver injury, and one had delayed growth and development. Eight died and 18 recovered satisfactorily. CONCLUSION: Maternal TB status during pregnancy, the epidemiological history, T-SPOT.TB and other TB-related aetiological tests and imaging are important for the early diagnosis and treatment of CTB, and are associated with a favourable outcome. ABBREVIATIONS: AFB: acid-fast bacilli; Amk: amikacin; Cs: cycloserine; CT: computed tomography; E: ethambutol; GeneXpert MTB/RIF: GeneXpert Mycobacterium tuberculosis and rifampicin resistance; H: isoniazid; IVF-ET: in-vitro fertilization-embryo transfer; Lzd: linezolid; Mfx: moxifloxacin; MTB: Mycobacterium tuberculosis; mNGS: next generation sequencing; MTB-DNA: Mycobacterium tuberculosis-deoxyribonucleic acid; Pto: protionamide; R: rifampicin; TB: tuberculosis; T-SPOT.TB: spot test of mycobacterium TB infection T-lymphocytes; Z: pyrazinamide.


Asunto(s)
Enfermedades del Recién Nacido , Mycobacterium tuberculosis , Tuberculosis Meníngea , Tuberculosis Resistente a Múltiples Medicamentos , Tuberculosis Pulmonar , Femenino , Recién Nacido , Humanos , Niño , Estudios Retrospectivos , Rifampin , Sensibilidad y Especificidad , Tuberculosis Pulmonar/diagnóstico , Mycobacterium tuberculosis/genética , Tuberculosis Meníngea/diagnóstico , Tuberculosis Meníngea/tratamiento farmacológico , Tuberculosis Meníngea/epidemiología , Tuberculosis Resistente a Múltiples Medicamentos/tratamiento farmacológico
5.
Aging (Albany NY) ; 14(7): 3313-3324, 2022 04 14.
Artículo en Inglés | MEDLINE | ID: mdl-35422450

RESUMEN

BACKGROUND: The MEG3/miR-181b signaling has been implicated in the pathogenesis of several diseases including Crohn's disease. This work aimed to study the correlation between SNPs in MEG3/miR-181b and the severity of anal abscess in patients with Crohn's disease. METHODS: Quantitative real-time PCR was performed to analyze the expression of MEG3 and miR-181b. ELISA was carried out to examine the expression of TNF-α, IL-1ß, IL-6, CRP, SSA, AAT, AAG and HPT in the peripheral blood of patients with Crohn's disease. Luciferase assay was performed to explore the role of miR-181b in the expression of MEG3 and TNF-α. RESULTS: The expression of MEG3 and miR-181b in the peripheral blood of patients with Crohn's disease was remarkably associated with the rs322931 and rs7158663 polymorphisms. rs322931 (C>T) in miR-181b and rs7158663 (G>A) in MEG3 significantly promoted the expression of TNF-α, IL-1ß, IL-6, CRP, SSA, AAT, AAG and HPT. Luciferase assay demonstrated that miR-181b was capable of repressing the expression of MEG3 and TNF-α through binding to their specific binding sites. Moreover, alteration of MEG3 and miR-181b expression also showed a remarkable impact on the MEG3/miR-181b/TNF-α signaling pathway in THP-1 cells. CONCLUSIONS: In conclusion, our study demonstrated that two SNPs, rs322931 (C>T) in miR-181b and rs7158663 (G>A) in MEG3, could aggravate the inflammatory response of anal abscess in patients with Crohn's disease via modulating the MEG3/miR-181b/TNF-α signaling pathway.


Asunto(s)
Absceso , Enfermedades del Ano , Enfermedad de Crohn , MicroARNs , ARN Largo no Codificante , Absceso/genética , Enfermedades del Ano/genética , Enfermedad de Crohn/complicaciones , Enfermedad de Crohn/genética , Humanos , Luciferasas , MicroARNs/genética , Polimorfismo de Nucleótido Simple , ARN Largo no Codificante/genética , ARN Largo no Codificante/metabolismo , Factor de Necrosis Tumoral alfa/genética
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda